Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol vs vaginal misoprostol

Stepwise oral misoprostol (50 μg followed by 100 μg) appears to be as effective as vaginal misoprostol (25 μg) for cervical ripening with a low incidence of hyperstimulation, no increase in side effects, a high rate of patient satisfaction, and is associated with a lower cesarean section rate.